EMEA-001964-PIP02-19
Key facts
| Invented name |
Epidyolex
|
| Active substance |
Cannabidiol
|
| Therapeutic area |
Neurology
|
| Decision number |
P/0095/2020
|
| PIP number |
EMEA-001964-PIP02-19
|
| Pharmaceutical form(s) |
Oral solution
|
| Condition(s) / indication(s) |
Treatment of Rett syndrome
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
GW Pharma (International) B.V.
E-mail: info@gwpharm.com |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|